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Abstract 
Background: The ubiquitin protein E3A ligase gene (UBE3A) gene is imprinted with maternal-specific expression in 
neurons and biallelically expressed in all other cell types. Both loss-of-function and gain-of-function mutations affect-
ing the dosage of UBE3A are associated with several neurodevelopmental syndromes and psychological conditions, 
suggesting that UBE3A is dosage-sensitive in the brain. The observation that loss of imprinting increases the dos-
age of UBE3A in brain further suggests that inactivation of the paternal UBE3A allele evolved as a dosage-regulating 
mechanism. To test this hypothesis, we examined UBE3A transcript and protein levels among cells, tissues, and species 
with different imprinting states of UBE3A.
Results: Overall, we found no correlation between the imprinting status and dosage of UBE3A. Importantly, we 
found that maternal Ube3a protein levels increase in step with decreasing paternal Ube3a protein levels during neu-
rogenesis in mouse, fully compensating for loss of expression of the paternal Ube3a allele in neurons.
Conclusions: Based on our findings, we propose that imprinting of UBE3A does not function to reduce the dosage of 
UBE3A in neurons but rather to regulate some other, as yet unknown, aspect of gene expression or protein function.
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Background
Genomic imprinting is a rare epigenetic phenomenon 
that leads to the differential expression of paternally and 
maternally derived alleles of a gene in a parent-of-origin 
dependent manner [50, 54]. It has been documented 
only in therian mammals and flowering plants and only 
at a few loci in mammals, of which fewer than half are 
imprinted in both mouse and human [1, 4, 8, 39, 42, 50, 
52]. Several theories have been proposed to explain the 
evolution and function of genomic imprinting (e.g., dos-
age regulation, complementation, parental conflict/
kinship, host defense, maternal time-bomb, and develop-
mental plasticity models), but there is currently no unify-
ing theory that can explain the conservation of genomic 
imprinting across taxa [2, 17–19, 35, 50, 51, 58, 59]. Thus, 
apart from downregulating or silencing the expression 
of one allele, the functional significance of imprinting is 
largely unknown. Nevertheless, imprinting is believed 
to be an important regulatory mechanism, inasmuch as 
almost all recognized imprinting abnormalities are asso-
ciated with pathological states [8, 49].
The ubiquitin protein E3A ligase gene (UBE3A) is 
located at the distal end of a cluster of imprinted genes 
on human chromosome 15q11-q13 and a homolo-
gous region on mouse chromosome 7C. In neurons of 
the central nervous system (CNS), UBE3A is imprinted 
with maternal-allelic expression, whereas in all other 
cell types, it is expressed from both alleles [11, 43, 62]. 
Imprinting of UBE3A is regulated by expression of 
the paternally expressed UBE3A antisense transcript 
(UBE3A-AS), which comprises the 3′ end of a long poly-
cistronic transcription unit (PTU) containing multiple 
clusters of C/D box small nucleolar RNAs (snoRNA) 
and the SNRPN-SNURF bicistronic transcript [7, 29, 30, 
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44]. In both mouse and human, expression of Ube3a-
AS/UBE3A-AS in cis is both necessary and sufficient to 
silence expression of the paternal Ube3a/UBE3A allele 
[ [31], [33] ], which, at least in mouse, appears to occur 
by inhibiting transcriptional elongation, giving rise to a 
paternally expressed, 5′-truncated transcript of unknown 
function [33, 38].
The UBE3A gene is highly conserved among verte-
brate and invertebrate species [6, 9, 21, 22, 61]; however, 
imprinting of UBE3A is believed to have evolved in the 
common ancestor of eutherian mammals after diver-
gence from the metatherian (marsupials) lineage, as stud-
ies to date show that UBE3A is biallelically expressed in 
tammar wallaby, platypus, chicken, and fruit-fly brain, 
and that there is no orthologous imprinted region detect-
able in marsupials or monotreme (prototherian) mam-
mals [9, 21, 41], suggesting that imprinting of UBE3A in 
neurons is somehow advantageous to biallelic expression 
in eutherian species. The snoRNAs located in 15q11-q13, 
which serve as the precursors of Ube3a-AS/UBE3A-AS, 
are also eutherian-specific and appear to have rapidly 
evolved in a lineage-specific manner [64]; however, the 
relationship, if any, between these transcripts or the evo-
lution of this region and imprinting of Ube3a/UBE3A is 
currently unknown.
Mutations or epimutations affecting the expression or 
function of UBE3A are associated with several neurode-
velopmental disorders and psychological conditions. 
Loss-of-function or loss-of-expression of the maternally 
inherited UBE3A allele causes Angelman syndrome (AS), 
which presents with intellectual disability, ataxia, epi-
lepsy, sleep disorders, and an atypical ‘happy’ disposition 
[26, 32, 60]. Conversely, maternally derived duplications 
of 15q11-q13 cause dup15q syndrome—a neurodevel-
opmental disorder distinctly different from AS—involv-
ing intellectual disability, ataxia, speech impairment, 
epilepsy, and autism spectrum disorder (ASD) [16, 20, 
36, 40, 47]. Although dup15q syndrome is a contiguous 
gene disorder, overexpression of UBE3A is believed to 
be the principal pathological mechanism underlying the 
syndrome, as UBE3A is the only maternally expressed 
gene located within the duplication and as the severity of 
the condition correlates with the number of copies and 
expression levels of UBE3A [47]. There are also reports 
of UBE3A gain-of-function mutations (e.g., biochemical 
and genetic) in individuals with ASD and other psycho-
logical conditions [37, 63]. Paternally inherited deletions 
of 15q11-q13, namely those involving the C/D box 
snoRNA SNORD116, result in Prader–Willi syndrome 
(PWS), which is characterized by dysregulated hunger 
and satiety patterns, abnormal thermoregulation, sleep 
disorders, and behavioral issues [45].
The notion that imprinting of UBE3A evolved as a 
dosage-regulating mechanism stems from the role of 
UBE3A in AS and dup15q syndromes and from observa-
tions showing that loss of Ube3a-AS reactivates paternal 
Ube3a expression, leading to an increase in Ube3a pro-
tein levels in the brain [5, 7, 13, 34]. In the present study, 
we compared UBE3A expression levels (RNA transcript 
and protein) between cells, tissues, and species with dif-
ferent imprinting states of UBE3A. We also examined 
parental Ube3a protein levels during the acquisition of 
the imprint in neurons. Overall, our findings show that 
the dosage of Ube3a/UBE3A is relatively constant regard-
less of its imprinting status, suggesting that imprint-
ing does not function to regulate the dosage of Ube3a/
UBE3A in neurons.
Results
Ube3a/UBE3A is highly expressed from the maternal allele 
in the CNS
To determine whether imprinting of Ube3a in neurons of 
the mouse CNS reduces the dosage of Ube3a relative to 
other tissues where Ube3a is biallelically expressed (non-
CNS), we compared the steady-state levels of Ube3a 
RNA (hereafter referred to as transcript) and Ube3a 
protein among tissues in adult wild-type mice. To esti-
mate the relative expression levels of the maternal Ube3a 
allele, we also examined mice with a paternally inherited 
mutation in the Ube3a gene [23]. For both Ube3am+/
p+ and Ube3am+/p− mice, Ube3a transcript levels were 
significantly higher in CNS (cortex and hippocampus) 
than in non-CNS (heart, kidney, liver, and lung) tissues 
[Ube3am+/p+: F(1, 15.8) = 55.6, p < 0.0001; Ube3am+/p−: 
F(1, 14) =  338.6, p  <  0.0001 (Fig.  1a)]. Likewise, Ube3a 
protein levels in both Ube3am+/p+ and Ube3am+/p− mice 
were significantly higher in CNS (cerebellum, cortex, hip-
pocampus) than in non-CNS (heart, liver, and lung) tis-
sues [Ube3am+/p+: F(1, 19) = 22.8, p < 0.0001; Ube3am+/
p−: F(1, 14) = 118.5, p < 0.001 (Fig. 1b)]. Neither Ube3a 
RNA or Ube3a protein levels were significantly different 
in the CNS of Ube3am+/p+ and Ube3am+/p− mice (RNA: 
t = 0.9, p = 0.8; protein: CNS, t = 2.1, p = 0.2), indicat-
ing that the relatively high level of Ube3a expression in 
mouse CNS is primarily attributable to expression of the 
maternal allele.
To confirm that the maternal Ube3a allele is highly 
expressed in the CNS, we used RNA-seq data to compare 
Ube3a transcript levels expressed from each parental 
allele within and among CNS (hippocampus) and non-
CNS (heart, liver, lung, and thymus) tissues in adult mice 
[25]. Total Ube3a transcript levels (i.e., those expressed 
by both maternal and paternal alleles) were significantly 
different among the tissues [F(4, 41.8) = 8.3, p < 0.0001], 
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with slightly higher, albeit not significant, Ube3a tran-
script levels in hippocampus compared to those in liver 
(t = 0.8, p = 0.9) and thymus (t = 0.1, p = 0.9) and sig-
nificantly higher transcript levels than those in heart 
(t = 2.9, p = 0.02) and lung [t = 4.7, p < 0.0001 (Fig. 1c)]. 
Importantly, we found that maternal Ube3a transcript 
levels in hippocampus were significantly higher than 
those expressed from either allele in all the other tissues, 
Fig. 1 Ube3a/UBE3A is highly expressed in mouse and human CNS tissues. a Ube3a transcript levels in adult Ube3am+/p+ (n = 4) and Ube3am+/p− 
(n = 3) CNS (cortex, hippocampus) and non-CNS (N-CNS; heart, kidney, liver, and lung) tissues. Levels are shown as the ratio of expression in tissues 
relative to heart. b Ube3a protein levels in adult Ube3am+/p+ (n = 4) and Ube3am+/p− (n = 3) CNS (cerebellum, cortex, hippocampus) and non-CNS 
(heart, liver, and lung). Levels are shown as the ratio of expression in tissues relative to heart. c Normalized FPKM values of total Ube3a transcripts 
and d maternal and paternal Ube3a transcripts in B6D2F1 mouse hippocampus, thymus, liver, lung, and heart (n = 6). e, f Normalized FPKM values 
of UBE3A transcripts in adult human tissues (GTEx: n ≥ 30; Fagerberg et al.: n = 3). Abbreviations n.s., not significant; *p < 0.05; **p < 0.001. Individual 
data points provided with mean (gray bar chart) and 95% confidence intervals
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whereas paternal Ube3a transcript levels in hippocampus 
were lower than those expressed from either allele in all 
the other tissues, with significantly lower levels relative 
to hippocampus, thymus, liver, and heart (paternal allele) 
(Fig. 1d and Additional file 1), confirming that the rela-
tively high levels of Ube3a expression in the CNS arise 
from the maternal allele.
To compare UBE3A expression levels between CNS 
and non-CNS tissues in human, we analyzed UBE3A 
transcript levels in 10 tissues (n  ≥  30) using RNA-seq 
data generated by the GTEx consortium [10] and in 12 
tissues (n = 3) using RNA-seq data generated by Fager-
berg et al. [12]. In the GTEx data set, UBE3A transcript 
levels were significantly different among the tissues [F(9, 
1129.8)  =  262.5, p  <  0.0001], with no significant effect 
of sex [F(1, 186.6) = 0.2, p = 0.6] or significant interac-
tion between tissue and sex [F(9, 1129.8] = 0.8, p = 0.6). 
Relative to brain, UBE3A transcript levels were similar 
to those in heart, adipose tissue, and esophagus, signifi-
cantly higher than those in lung and skin, but signifi-
cantly lower than those in blood vessel, muscle, thyroid, 
and nerve (tibial) (Fig.  1e and Additional file  2). In the 
Fagerberg data set, UBE3A transcript levels were also 
significantly different among the tissues [F(11, 14) = 7.5, 
p  <  0.0004]. Relative to cortex, UBE3A transcript levels 
were similar to those in bone marrow, esophagus, heart, 
kidney, liver, skin, and thyroid, and significantly higher 
than those in gallbladder, lung, spleen, and stomach 
(Fig. 1f and Additional file 3).
Taken together, these findings show that in both mouse 
and human cells, expression levels of Ube3a/UBE3A in 
CNS are generally equal to or higher than those in non-
CNS tissues, despite the different imprinting states.
Maternal Ube3a compensates for loss of paternal Ube3a 
expression during neurogenesis
Our findings that the maternal Ube3a allele is highly 
expressed in brain prompted us to examine the expres-
sion of each parental Ube3a allele during the acquisition 
of the imprint in neurons. Using the Ube3aYFP reporter 
mouse model [11], we compared paternal  Ube3aYFP 
(Ube3am+/pYFP) and maternal  Ube3aYFP (Ube3amYFP/p+) 
protein levels in neural stem/progenitor cells (NSC) and 
in NSC-derived neurons over the course of 16  days of 
differentiation in  vitro. In NSC cultures, maternal and 
paternal  Ube3aYFP protein levels were approximately 
equal [maternal/paternal ratio = 48.3:51.7; F(1, 2) = 0.8, 
p = 0.5 (Fig. 2a, b)], which was not affected by the parent-
of-origin of the  Ube3aYFP reporter allele [F(1, 2) = 1.31, 
p  =  0.4] or number of passages in culture (data not 
shown). In NSC-derived neurons, paternal and maternal 
 Ube3aYFP protein levels were approximately equal at 1 day 
post-differentiation (DPD; t = 0.9, p = 0.4); however, at 
4, 8, and 16 DPD, maternal  Ube3aYFP protein levels were 
significantly higher than paternal  Ube3aYFP protein levels 
(4 DPD: t = 2.9, p = 0.004; 8 DPD: t = 5.7, p < 0.0001; 
and 16 DPD: t = 11.8, p < 0.0001), with the protein lev-
els produced by each parental allele diverging at a similar 
rate (slope: maternal =  0.76, paternal = −0.56; Fig.  2c, 
d). As a result, total  Ube3aYFP protein levels in neurons 
remained relatively constant during the 16 days of differ-
entiation [F(3, 3) = 1.3, p = 0.3 (Fig. 2e)], demonstrating 
that the maternal Ube3a allele compensates for loss of 
expression of the paternal Ube3a allele during the acqui-
sition of the imprint in neurons. In contrast, paternal and 
maternal  Ube3aYFP protein levels were approximately 
equal in NSC-derived astrocytes at 16 DPD [t  =  0.3, 
p  =  0.8; maternal/paternal ratio  =  45.4:54.6 (Fig.  2f )]. 
Taken together, these findings indicate that imprinting of 
Ube3a is initiated upon neuronal differentiation and that 
the maternal Ube3a allele fully compensates for loss of 
expression of the paternal allele in neurons.
Ube3a/UBE3A protein levels in the mouse and opossum 
brain do not correlate with their imprinting status
The UBE3A gene is highly conserved among vertebrates, 
but its specific location within the AS-PWS imprinted 
region in eutherian (placental) mammals suggests that 
imprinting of UBE3A evolved subsequent to divergence 
of the eutherian and metatherian (marsupial) lineages. 
Expression data from unspecified tissues of tammar wal-
laby (Macropus eugenii) and platypus (Ornithorhynchus 
anatinus) brain show that UBE3A is not imprinted in 
these species, consistent with this evolutionary scenario 
[41]. If genomic imprinting of UBE3A arose in the com-
mon ancestor of modern eutherian mammals as an epi-
genetic mechanism to reduce the dosage of UBE3A in 
neurons, we should expect levels of UBE3A in the CNS 
of eutherian mammals to be reduced relative to that in 
other (non-CNS) cell types, but have no expectation of 
a similar pattern of relative reduction in CNS cells of 
non-eutherian mammals. To test this hypothesis, we 
contrasted Ube3a/UBE3A protein levels in non-CNS 
tissues and cortex, within and between mouse and the 
gray, short-tailed opossum (Monodelphis domestica), a 
metatherian mammal lacking an orthologous AS-PWS 
region. We first confirmed the non-imprinted imprinting 
status of UBE3A in opossum cortex using RNA-seq. We 
next used western blot analysis of UBE3A protein levels 
to obtain measures of relative expression among opos-
sum tissues and normalized, absolute expression between 
mouse and opossum cortex.
Analysis of RNA-seq data derived from opossum cor-
tex (n = 4) revealed 4 informative SNVs in UBE3A that 
were equally represented from each parental allele [SNV-
1: X2 = 0.2, p = 0.7; SNV-2: X2 = 0.02, p = 0.9; SNV-3: 
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X2 = 0.9, p = 0.7; SNV-4: X2 = 2.5, p = 0.1 (Fig. 3a and 
Additional file  4)]. Combined, the maternal-to-pater-
nal allelic ratio of UBE3A transcripts was 49:51 (95% 
CI maternal: 46–51, paternal: 51–54), confirming that 
UBE3A is biallelically expressed in opossum brain. Align-
ment of the mouse, human, and opossum Ube3a/UBE3A 
amino acid sequences revealed a high percent identity 
(93–95% identical) among the three species, indicating 
that opossum UBE3A is sufficiently similar to the euthe-
rian protein to enable meaningful comparisons by west-
ern blot (Additional file 5). Consistent with our findings 
in mice, UBE3A protein levels in the opossum CNS (cor-
tex and hippocampus) were significantly higher than 
those in non-CNS tissues [heart and lung; F(1, 11) = 38.6, 
p < 0.001 (Fig. 3b)], suggesting that an increased level of 
expression in cortex may be a conserved characteristic of 
all therian mammals, independent of imprinting. Impor-
tantly, direct comparisons between mouse and opossum 
showed significantly higher levels of Ube3a protein in the 
mouse cortex (n = 4) than in the opossum cortex [t = 2.6, 
p < 0.05 (Fig. 3c)]. Thus, despite imprinted expression of 
Ube3a in the mouse CNS, Ube3a protein levels in cortex 
Fig. 2 Maternal Ube3a compensates for loss of paternal Ube3a expression during neurogenesis. a Immunofluorescence images of primary neuro-
spheres derived from the hippocampal formation of prenatal Ube3am+/pYFP and Ube3amYFP/p+ mice. Scale bar = 100 µm. b Western blot analysis of 
Ube3a and  Ube3aYFP protein in NSC derived from Ube3am+/pYFP, Ube3amYFP/p+ and wild-type mice. c Immunofluorescence images of Ube3am+/pYFP 
and Ube3amYFP/p+ NSC-derived neurons at 1 and 16 days post-differentiation (DPD; scale bar = 25 µm). d  Ube3aYFP intensity values of paternal 
 Ube3aYFP and maternal  Ube3aYFP protein levels in primary neurons at 1 DPD (Ube3am+/pYFP: n = 13; Ube3amYFP/p+ n = 14), 4 DPD (Ube3am+/pYFP: 
n = 14; Ube3amYFP/p+: n = 13), 8 DPD (Ube3am+/pYFP: n = 15; Ube3amYFP/p+: n = 15), and 16 DPD (Ube3am+/pYFP: n = 14; Ube3amYFP/p+: n = 13). Ratios 
normalized relative to total  Ube3aYFP protein levels at 1 DPD. e Total  Ube3aYFP protein levels in neurons during neuronal development. f Normalized 
paternal  Ube3aYFP and maternal  Ube3aYFP protein levels in Ube3am+/pYFP and Ube3amYFP/p+ NSC-derived astrocytes at 16 DPD (Ube3am+/pYFP: n = 15; 
Ube3amYFP/p+: n = 14). Abbreviations TOPRO-3, nuclear stain; n.s., not significant; *p < 0.05; **p < 0.001. Individual data points provided with 95% 
confidence intervals
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are substantially higher than those produced by biallelic 
expression in the opossum cortex.
Imprinting of Ube3a during neurogenesis is 
developmentally regulated
Given our findings that expression of the paternal Ube3a 
allele gradually decreases during neuronal development 
in vitro, we decided to examine the developmental tim-
ing of the acquisition of the imprint in vivo by examining 
parental  Ube3aYFP protein expression in two neurogenic 
regions of the adult mouse brain: (1) the subgranular 
zone of the dentate gyrus (SGZ) and (2) the subven-
tricular zone of the lateral ventricles (SVZ) and rostral 
migratory stream (RMS). In the SGZ, neural stem cells 
differentiate into mature granular neurons that integrate 
into the dentate gyrus through migration to the granular 
cell layer (GCL), whereas in the SVZ, neural stem cells 
differentiate while migrating through the RMS to the 
olfactory bulb, where they differentiate into mature olfac-
tory neurons [28].
 In the SVZ of adult mice, paternal  Ube3aYFP protein 
was detected in NSC/progenitor cells located along the 
lateral ventricles and expressing the polysialylated-neural 
cell adhesion molecule (PSA-NCAM) and nestin (NES) 
(Additional File 6). In the RMS, paternal  Ube3aYFP pro-
tein was detected in immature neurons expressing dou-
blecortin (DCX); however, in the olfactory bulb, paternal 
 Ube3aYFP protein was barely detectable in mature neu-
rons expressing the RNA-binding protein, Fox-1 homolog 
3 [RBFOX3 (Fig.  4a)]. In the dentate gyrus, paternal 
 Ube3aYFP protein was only detected in the SGZ, where it 
was present in radial glia (i.e., putative neural stem cells) 
expressing glial fibrillary acidic protein (GFAP), progeni-
tor cells expressing PSA-NCAM, and immature neurons 
expressing DCX but not in mature neurons expressing 
RBFOX3 in the GCL (Fig.  4b, c). In contrast, maternal 
 Ube3aYFP protein was detected in each neurogenic cell 
type and in mature neurons throughout the CNS (Addi-
tional file 6). Taken together, these observations indicate 
that expression of the paternal Ube3a allele is silenced at 
a specific stage of neurogenesis, preceding the develop-
mental maturation of neurons.
Ube3a is biallelically expressed in myenteric neurons of the 
PNS
Lastly, we asked whether Ube3a is also imprinted in 
neurons of the peripheral nervous system (PNS). To test 
this hypothesis, we examined parental  Ube3aYFP pro-
tein levels in myenteric neurons in Auerbach’s ganglia 
in the colon. In adult Ube3amYFP/p+ and Ube3am+/pYFP 
mice, maternal  Ube3aYFP and paternal  Ube3aYFP protein 
were detected in mature myenteric neurons expressing 
RBFOX3 (Fig.  5a), in contrast to hippocampal granular 
neurons in which paternal  Ube3aYFP protein was almost 
undetectable (Fig.  5b). The levels of  Ube3aYFP protein 
expressed from each allele in myenteric neurons, how-
ever, was skewed, with higher levels of maternal  Ube3aYFP 
protein albeit not significantly different (maternal/pater-
nal ratio  =  60:40; F(1, 4.2)  =  6.3, p  =  0.06) (Fig.  5b). 
Although studies of additional PNS neurons are needed, 
these findings suggest that imprinting of Ube3a is likely 
specific to neurons of the CNS.
Discussion
In this study, we examined whether imprinting func-
tions to reduce the dosage of Ube3a/UBE3A (i.e., levels of 
transcripts and/or protein) in neurons. Our results show 
that imprinting of the mouse Ube3a gene in neurons is 
Fig. 3 Ube3a protein levels are higher mouse and opossum brain despite different imprinting states of Ube3a/UBE3A. a UBE3A allelic ratio 
expressed in adult opossum cortex (n = 4) estimated from four single-nucleotide variants (SNV). b Normalized UBE3A protein levels in adult opos-
sum CNS (cortex and hippocampus) and non-CNS (N-CNS; heart and lung) tissues (n = 4). c Normalized UBE3A/Ube3a protein levels in adult mouse 
(n = 4) and opossum (n = 4) cortex. Abbreviations n.s., not significant; *p < 0.05; **p < 0.001. Individual data points provided with mean (gray bar 
chart) and 95% confidence intervals
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achieved through increasing expression of the maternal 
Ube3a allele in step with decreasing expression of the 
paternal Ube3a allele that occurs prior to a specific devel-
opmental time point during neurogenesis. These com-
pensating allelic expression states maintain a relatively 
constant level of Ube3a protein in neurons and relatively 
high levels of Ube3a RNA and protein in the CNS. Over-
all, we found that the expression levels of Ube3a/UBE3A 
are relatively constant among tissues and between 
eutherian and metatherian mammals, despite different 
imprinting states. Taken together, these findings suggest 
that the acquisition of UBE3A imprinting in eutherian 
mammals coincided with increased expression levels, 
supporting the conclusion that imprinting of UBE3A did 
not evolve as a dosage-regulating mechanism in neurons.
The dosage model of genomic imprinting suggests that 
imprinting evolved at some loci to reduce the expression 
levels of the gene by half [50]. For example, the paternal 
allele of the Murr1 gene is imprinted in neurons during 
brain development by the paternally expressed U2af1-rs1 
antisense transcript, leading to a substantial reduction in 
Murr1 RNA levels in the postnatal brain [57]. Addition-
ally, differential imprinting (i.e., monoallelic and bial-
lelic) of the Igf2 gene in neurogenic niches of the adult 
mouse brain has been shown to regulate autocrine and 
paracrine roles of Igf2 in a dose-dependent manner [14]. 
In contrast to these two genes, we show that the levels 
of Ube3a/UBE3A RNA and protein are remarkably sta-
ble among tissues and species with different imprint-
ing states, which stems from increased expression of 
the maternal Ube3a allele during the acquisition of the 
imprint. These findings are consistent with previous stud-
ies showing relatively constant levels of Ube3a/UBE3A 
transcripts during mouse brain development and among 
human tissues [15, 27] and the notion that dosage com-
pensation may in fact be a common feature of imprinted 
genes, as suggested previously [3].
Given the importance of UBE3A in the brain and the 
conservation of the imprint in mouse and human neu-
rons, and perhaps all placental mammals, it is likely that 
Fig. 4 Imprinting of Ube3a is developmentally regulated. a Immunofluorescence images of paternal  Ube3aYFP protein expression in the subven-
tricular zone, rostral migratory stream, and olfactory bulb of Ube3am+/pYFP mice. Immature and mature neurons were identified by DCX and RBFOX3 
staining, respectively (×10 magnification; scale bar = 100 µm). b Immunofluorescence images of paternal  Ube3aYFP protein expression in the 
dentate gyrus of Ube3am+/pYFP mice (×10 magnification; scale bar = 20 µm). c Immunofluorescence images of paternal  Ube3aYFP in putative neural 
stem cells (GFAP labeled radial glia), neural progenitor cells (PSA-NCAM), immature neurons (DCX), and mature neurons (RBFOX3) of the subgranular 
zone (×43 magnification; scale bar = 20 µm). Abbreviations OB, olfactory bulb; RMS, rostral migratory stream; SVZ, subventricular zone; LV, lateral 
ventricle; DG, dentate gyrus; GCL, granular cell layer; SGZ, subgranular zone; TOPRO-3, nuclear stain; NSC, neural stem cell
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imprinting of UBE3A is a functionally relevant process in 
neurons that is somehow linked to the neuron-specific 
expression of the PWS polycistronic transcription unit 
(PWS-PTU). For example, imprinting of UBE3A might 
have evolved as a means to permit simultaneous expres-
sion of both UBE3A and the PWS-PTU in neurons, simi-
lar to that proposed in the complementation model of 
genomic imprinting [24]. Alternatively, transcription of 
UBE3A-AS across UBE3A or, perhaps, UBE3A-AS itself 
might expand the functional repertoire of UBE3A iso-
forms (coding and non-coding) expressed in neurons. 
Unlike most imprinted genes regulated by an antisense 
transcript, studies in mouse show that Ube3a-AS inhib-
its transcriptional elongation of the paternal Ube3a allele, 
resulting in a paternally expressed, 5′-truncated tran-
script expressed exclusively in neurons [33, 38]. Given 
recent findings that mouse Ube3a expresses a non-cod-
ing isoform that is important for synapse development 
[55], it is tempting to speculate that the 5′-truncated 
Ube3a transcript is in fact a functional transcript rather 
than just a by-product of the imprinting mechanism.
Conclusions
Although future studies are needed to resolve the func-
tional significance of imprinting of UBE3A in neurons, 
the findings presented here provide evidence of an evolu-
tionarily constrained, developmentally regulated process 
that maintains the dosage of UBE3A despite its monoal-
lelic expression in neurons. Understanding the function 
of imprinting of UBE3A is directly relevant to under-
standing the function of UBE3A in the brain, and under-
standing the imprinted regulation of UBE3A is critically 
important for approaches aimed at reactivating expres-
sion of the paternal UBE3A allele as a therapy for indi-
viduals with Angelman syndrome.
Methods
Analysis of Ube3a/UBE3A expression levels in tissues
Animals
C57BL/6J mice were obtained from The Jackson Labo-
ratories (http://www.jax.org). The Ube3am−/p+ mouse 
model was obtained from the laboratory of Dr. Arthur 
Beaudet (Baylor College of Medicine). Ube3am−/p+ and 
Fig. 5 Ube3a is biallelically expressed in myenteric neurons of the PNS. a Immunofluorescence images of neurons in the myenteric ganglia 
of the peripheral nervous system of Ube3am+/pYFP and Ube3amYFP/p+ mice. b Immunofluorescence images of granular neurons in the dentate 
gyrus of Ube3am+/pYFP and Ube3amYFP/p+ mice. c Normalized intensity values of  Ube3aYFP protein levels in myenteric neurons of Ube3am+/pYFP and 
Ube3amYFP/p+ mice (n = 3 per genotype; Ube3am+/pYFP: n = 22 neurons; Ube3amYFP/p+: n = 28). Abbreviations TOPRO-3, nuclear stain; n.s., not signifi-
cant. Individual data points provided with mean (gray bar chart) and 95% confidence intervals
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animals were generated by crossing wild-type C57BL/6J 
males with Ube3am+/p− females, and Ube3am+/p− animals 
were generated by crossing Ube3am+/p− males with wild-
type C57BL/6J females. Animals were maintained by 
the Texas A&M University Comparative Medicine Pro-
gram. All procedures involving animals were approved 
by the Texas A&M Institutional Animal Care and Use 
Committee.
Quantitative RT‑PCR
Total RNA was extracted from tissue samples using 
the PureLink RNA Mini Kit (Life Technologies, Carls-
bad, CA). First-strand cDNA synthesis was performed 
using: (1) the Superscript III First-Strand Synthesis kit 
and oligo-dT primers (messenger RNA [mRNA]; Life 
Technologies) and (2) the High Capacity RNA to cDNA 
kit and random hexamer primers (total RNA [toRNA]; 
Life Technologies). Real-time PCR was performed using 
the TaqMan Gene Expression Master Mix and TaqMan 
Gene Expression Assays per manufacturer’s protocol 
(Life Technologies). Beta-2 microglobulin (TaqMan Assay 
#Mm00437762_m1) was used as an internal control. 
TaqMan Assay #Mm00839910_m1 was used to assess 
Ube3a toRNA and mRNA levels. The primer and probe 
set targets an amplicon of 121 base pairs that spans exons 
6 and 7 of Ube3a isoforms 1 and 3 and exons 8 and 9 of 
Ube3a isoform 2. The reactions were performed using an 
ABI 7900HT real-time PCR machine.
Statistical analysis
Measurements for inferential statistics were taken using nor-
malized ΔCt values (2−�Ct = 2−Ct [target]−Ct [internal control]) , 
as outlined previously [46]. A Shapiro–Wilk goodness-of-
fit test was used to test normality of sample distribution. A 
mixed-effect model was used to examine the effect of tis-
sue on Ube3a RNA transcript levels, with sample ID as a 
random effect to account for repeated measurements of 
individual. A Tukey HSD multiple comparison test was 
used for pair-wise comparisons of tissues. The tissues 
were then grouped as CNS or non-CNS, and a mixed-
effect model was used to examine the effect of tissue type 
on Ube3a RNA levels, with sample ID as a random effect. 
Descriptive statistics consist of ΔΔCt values 
(
2
−Ct
= 
2−(Ct [target]−Ct [internal control])−(Ct [target]−Ct [internal control])
)
 ; 
target = Ube3a, internal control = beta-2 microglobulin).
Western blot analysis
Total protein was isolated by homogenizing tissue 
samples with a 1% Nonidet P40/0.01% SDS lysis buffer 
and protease inhibitors (Roche, Indianapolis, IN). The 
resulting lysates were mixed 1:1 with Laemmli loading 
buffer (Bio-Rad, Hercules, CA) and heated to 95 °C for 
5 min. The samples were then resolved on a SDS-PAGE 
gel (7.5%) at 25  V for approximately 12  h and then 
transferred to nitrocellulose membranes at 100  V for 
2 h. To normalize samples, the membranes were treated 
with Ponceau stain (Sigma-Aldrich) and digitally pho-
tographed. The membranes were then blocked in 5% 
milk in Tris-buffered saline plus Tween 20 (T-TBS) 
for 1 h at room temperature. Ube3a primary antibody 
(Additional file 7) was diluted in 2.5% milk/T-TBS and 
incubated on the membrane for 1 h at room tempera-
ture. After three 15 min washes in T-TBS, the second-
ary antibody (Additional file  7) was diluted 1:2000 in 
2.5% milk/T-TBS and incubated on the membrane 
for 1  h at room temperature. Three 15  min washes in 
T-TBS were performed before developing with Clar-
ity Western ECL Substrate (Bio-Rad), according to 
the manufacturer’s protocol. Membranes were imaged 
using the FluorChem system.
Statistical analysis
Digital images of western blot membranes (16bit.tif ) 
were imported into ImageJ, and Ube3a protein levels 
were quantified using the Gel Analysis feature. Protein 
levels were quantified (as percentage) and then normal-
ized by the amount of total protein per sample using a 
Ponceau stain. A Shapiro–Wilk goodness-of-fit test was 
used to test normality of sample distribution. A linear 
mixed-effects model was used to examine the associa-
tion of tissue on Ube3a protein levels, with tissue mod-
eled as a fixed, categorical effect and sample ID modeled 
as a random effect to account for repeated measurements 
of individual. A Tukey HSD multiple comparison test 
was used for pair-wise comparisons of tissues. The tis-
sues were then grouped as CNS or non-CNS, and a lin-
ear mixed-effects model was used to examine the effect 
of tissue type on Ube3a protein levels, with sample ID 
included as a random effect. Descriptive statistics consist 
of Ube3a protein levels relative to heart.
RNA‑sequencing analysis in mouse tissues
Data from Keane et al. [25]: Samples consisted of 76 bp 
paired-end (PE) libraries generated from total RNA iso-
lated from heart, liver, lung, thymus, and hippocampus of 
8-week-old B6D2F1 hybrid mice (C57BL/6 male X DBA 
female; n =  6). FASTQ files were downloaded from the 
NCBI GEO SRA (accession: ERP000591) and aligned to 
the mouse reference genome (mm9) using the default set-
tings in TopHat, with the following option: -b2 sensitive.
Normalized RNA steady-state levels of the RefSeq 
gene annotation were estimated for each sample using 
Cuffnorm with the following option: -u. The FPKM value 
of Ube3a transcripts for each sample was extracted from 
the output file and used for descriptive and inferential 
statistics.
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Statistical analysis
The parental allelic ratio of Ube3a for each tissue was deter-
mined using single-nucleotide polymorphisms (SNPs) 
located in Ube3a exon 5 (SNP-1 =  chr7:66,527,581) and 
8 (SNP-2 =  chr7:66,541,539). Raw counts of the 2 SNPs 
were determined using the CLC Genomics Workbench 
quality-based variant detection module with the follow-
ing settings: neighborhood radius  =  5; maximum gap 
and mismatch count = 2, minimum neighborhood qual-
ity = 15, minimum central quality = 20, ignore non-spe-
cific matches, minimum coverage = 20, minimum variant 
% = 1. The raw counts of each SNP for each sample and 
tissue were then used to estimate the fragments per thou-
sand per million (FPKM) values of Ube3a transcripts of 
the parental alleles using the following equations:
A mixed-effect model was used to examine the effect of 
tissue and allele on Ube3a transcript levels (full factorial), 
with sample ID as a random effect to account for repeated 
measurements of individual. A Dunnett’s–Hsu multiple 
comparison test was used to compare total Ube3a tran-
script levels between hippocampus and each tissue, and 
a Dunnett’s–Hsu multiple comparison test was used to 
compare maternal and paternal Ube3a transcript levels 
between hippocampus and each allele of each tissue.
RNA‑sequencing analysis in human tissues
Data from Fagerberg et  al. [12]: Samples consisted of 
100  bp PE sequencing libraries generated from mRNA 
isolated from 12 human tissues. Three samples per tis-
sue were used for the analysis. FASTQ files were down-
loaded (http://www.ebi.ac.uk/arrayexpress/; accession: 
E-MTAB-1733) and aligned to the human reference 
genome (hg19) using the default settings in TopHat. 
Normalized FPKM values of the RefSeq gene annotation 
were estimated using Cuffnorm using the default settings 
and the following option: -u. The FPKM value of UBE3A 
for each sample was extracted from the output file and 
used for descriptive and inferential statistics.
Data from GTEx: The FPKM values and accompany-
ing information were downloaded for UBE3A from the 
GTEx Portal (http://www.gtexportal.org/home/GTEx_
Analysis_V4_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.
gct) [10, 53]. The initial data set consisted of 25 differ-
ent histologic samples derived from 175 individuals 
(1518 tissue samples). Only tissues for which at least 30 
samples were available were included in the inferential 
analyses (1227 tissue samples from 10 tissues): adipose 
tissue (n = 111), brain (n = 296), blood vessels (n = 138), 
Maternal allele =
(((∑
SNP− 1maternal
)
/
(∑
SNP− 1total
)
+
(∑
SNP − 2maternal
)
/
(∑
SNP− 2total
))
/2
)
× FPKM
Paternal allele =
((∑
SNP− 1paternal
)
/
(∑
SNP− 1total
)
+
(∑
SNP− 2paternal
)
/
(∑
SNP− 2total
))
/2)× FPKM
esophagus (n = 34), heart (n = 103), lung (n = 113), mus-
cle (n = 132), nerve (n = 86), skin (n = 114), and thyroid 
(n = 100). A total of 291 tissue samples from 14 tissues 
were excluded. Blood samples were also excluded from 
inferential analysis.
Statistical analysis
A mixed-effect model was used to examine the effect of 
tissue on UBE3A transcript levels, with sample ID as a 
random effect to account for repeated measurements of 
individual. For the GTEx data set, tissue and sex were 
modeled as fixed effects (full factorial), with sample ID as 
a random effect. A Dunnett’s–Hsu multiple comparison 
test was used to compare UBE3A transcript levels among 
tissues relative to the brain. Goodness-of-fit of models 
was assessed by AIC and BIC values and visual inspec-
tion of diagnostic residual plots.
Analysis of allelic  Ube3aYFP in neural stem cells 
and differentiated neurons
Animals
The Ube3aYFP mouse model was obtained from the 
laboratory of Dr. Arthur Beaudet (Baylor College of 
Medicine). Ube3amYFP/p+ animals were generated by 
crossing wild-type C57BL/6J males with Ube3am+/pYFP 
females, and Ube3am+/pYFP animals were generated by 
crossing Ube3am+/pYFP males with wild-type C57BL/6J 
females. Wild-type mice consisted of siblings lacking the 
Ube3aYFP allele. PCR to determine the genotypes of mice 
(i.e., Ube3am+/p+ or Ube3aYFP) were performed using 
methods described previously [11].
Neural stem cell cultures
Neural stem cell cultures were established from 
Ube3am+/p+, Ube3amYFP/p+, and Ube3am+/pYFP mice 
using methods described previously [48]. Briefly, the 
hippocampal formation (HF) was removed from fetuses 
at embryonic day 17.5 (E17.5), digested using a 10× 
Trypsin–EDTA solution, triturated into a single cell 
suspension, and then seeded in neural stem cell (NSC) 
medium, consisting of DMEM-F12 (Invitrogen, Carls-
bad, CA), B-27 supplement (Invitrogen), progesterone, 
putrescine (Sigma-Aldrich), epidermal growth factor 
(Sigma-Aldrich), glucose, penicillin/streptomycin (Inv-
itrogen), insulin–transferrin–sodium selenite (Sigma-
Aldrich), HEPES, and heparin. The NSC cultures were 
maintained in humidified incubators at 37  °C and 5% 
 CO2. Every 3–4 days, the neurospheres were dissociated 
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with TrypLE (Invitrogen) for 20  min and then resus-
pended in NSC media.
Western blot analysis
Western blot analysis of Ube3a and  Ube3aYFP protein 
levels in NSC cultures was performed using methods 
described above.
Statistical analysis
A mixed-effect model was used to examine the effect of 
allele (i.e., Ube3a or Ube3aYFP) and parent-of-origin (i.e., 
maternal or paternal) on Ube3a and  Ube3aYFP protein 
levels (full factorial), with sample ID as a random effect to 
account for repeated measurements.
Neural stem cell differentiation
To differentiate NSC cultures, neurospheres were first 
dissociated using TrypLE (Invitrogen) following the 
manufacturer’s protocol. The dissociated cells were then 
resuspended in neuronal growth media (Neurobasal-A 
[Invitrogen], B-27 supplement [Invitrogen], and Glu-
tamax [Invitrogen]) and plated on glass coverslips coated 
with poly-ornithine [Sigma-Aldrich] and laminin [Invit-
rogen] at a density of 380,000 cells per well in a 12-well, 
cell-culture plate; the plates were maintained in humidi-
fied incubators at 37 °C and 5%  CO2.
Immunofluorescence imaging of  Ube3aYFP
Immunofluorescence imaging was used to quantify 
 Ube3aYFP protein levels in differentiated neurons as previ-
ously described [11]. Briefly, at 1, 4, 8, and 16 days post-
differentiation (DPD; day of differentiation  =  0 DPD), 
differentiated cells were washed twice with 1× PBS, fixed 
in 4% paraformaldehyde in PBS for 15  min, and then 
washed three times in 1× PBS. The cells were blocked in 
0.3% Triton-X100 in PBS (T-PBS) plus 5% goat or donkey 
serum for 1–2 h at room temperature with gentle agita-
tion. Cells were incubated with the primary antibodies 
(Additional file  7) for 24  h at 4  °C with gentle agitation. 
Cells were washed 3 times in 0.1% Tween 20 1× PBS 
for 15  min each and then incubated with fluorescently 
labeled secondary antibodies (Additional file 7) for 24 h at 
4 °C in the dark. Cells were then washed 4 times in 0.1% 
Tween 20 1× PBS for 15  min each. Nuclei were labeled 
using TOPRO-3(Invitrogen) at a dilution of 1:1000 in 
the third wash. Coverslips were mounted on glass slides 
with Vectashield (Vector Laboratories, Burlingame, CA) 
mounting reagent. Confocal images were obtained using 
a LSM 510 META NLO multiphoton microscope (Zeiss, 
Oberkochen, Germany). Images of the individual neurons 
were taken at 43× magnification. Images were imported 
into ImageJ and converted to the RGB color format. 
The Plot Profile feature was then used to determine the 
median gray value of  Ube3aYFP in individual neurons. 
Neurons and astrocytes were identified by immunoreac-
tivity with the Tubb3 and GFAP antibodies, respectively.
Statistical analysis
To examine the effect of day on  Ube3aYFP protein levels, a 
linear regression model was used with normalized inten-
sity values of  Ube3aYFP as the dependent variable and 
days post-differentiation (DPD) and allele (i.e., maternal 
and paternal) as fixed effects. To compare maternal and 
paternal  Ube3aYFP protein levels at each time point, a 
least square means contrast linear regression model was 
used with normalized gray values of  Ube3aYFP protein 
levels as the dependent variable and DPD (dummy vari-
able) and allele as fixed effects.
Analysis of opossum Ube3a/UBE3A expression
Animals
For the analysis of UBE3A protein levels, opossum (Mono-
delphis domestica) tissues (cortex, hippocampus, heart, and 
lung) samples were obtained from a colony at the Compar-
ative Medicine Program facilities at Texas A&M University. 
All animals were derived from an outbred stock (LL1) that 
was founded using wild animals captured in Eastern Bra-
zil. All procedures involving animals were approved by the 
Texas A&M Institutional Animal Care and Use Commit-
tee. For the allelic expression analysis of UBE3A, opossum 
fetal brain (cortex) samples were obtained at 13 days post-
copulation (d.p.c.) from F1 animals derived from reciprocal 
crosses of two semi-inbred stocks (LL1 and LL2) [56].
RNA‑seq analysis
The brain tissues were homogenized in TRI Reagent 
(Invitrogen) and total RNA was extracted using BCP 
(1-bromo-2 chloropropane), precipitated with isopro-
panol, and resuspended in RNase-free water. Poten-
tial DNA contamination was removed by both DNase I 
treatment and DNA removal columns in Qiagen RNe-
asy Plus Mini kit (Qiagen, CA). RNA-seq libraries were 
made using the Illumina TruSeq RNA Sample Prep 
Kit (Illumina Inc., CA), and sequenced on an Illumina 
HiSeq  2000 instrument (Illumina Inc., CA). Details on 
RNA-seq data analysis could be found in Wang et al. [56].
Statistical analysis
A Pearson’s two-sided Chi-square test of the allelic 
counts of each SNV was used to determine the whether 
the allelic ratios of UBE3A were equal (Ho: maternal/
paternal = 50:50; Ha: maternal/paternal = 50:50).
Western blot analysis
Total protein was isolated from adult (21-week-old) 
opossum tissues (n  =  4) and adult (8-week-old) mouse 
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cortex (n  =  4) as described above. For the analysis of 
UBE3A protein levels among opossum tissues, a single 
western blot was performed for each animal for all tis-
sues. UBE3A protein levels were estimated and normal-
ized as described above. For the comparison of Ube3a/
UBE3A protein levels between opossum and mouse 
cortex, samples were run on a single western blot, and 
Ube3a/UBE3A protein levels were normalized and com-
pared as described above.
Statistical analysis
To compare UBE3A protein levels among opossum tis-
sues, a mixed-effect model was used with normalized 
UBE3A protein levels as the dependent variable, tis-
sue as a fixed effect, and sample ID as a random effect 
to account for repeated measurements of individual. To 
compare Ube3a/UBE3A protein levels between mouse 
and opossum cortex, a two-tailed Welsh t test was 
performed.
Analysis of  Ube3aYFP in neurogenic niches of the adult 
mouse brain
Immunofluorescence imaging of  Ube3aYFP
Ube3am+/pYFP and Ube3amYFP/p+ adult mice (6-week-old) 
were anesthetized with 0.5–1.0 mL of 20 mg/mL Avertin 
(Sigma-Aldrich, St. Louis, MO) via intraperitoneal injec-
tion. Mice were perfused with ice-cold phosphate-buff-
ered saline (PBS) and 4% paraformaldehyde. Dissected 
brains were post-fixed in 4% paraformaldehyde solution 
for approximately 12  h and then cryoprotected in 30% 
sucrose solution. Fifty µm sections (sagital and coronal) 
were cut on a cryostat and stored in PBS. For immu-
nostaining, sections were blocked in 0.3% Triton-X100 in 
PBS (T-PBS) plus 5% serum (goat or donkey) for 1–2 h 
at room temperature in a humidified chamber with gen-
tle agitation. Primary antibodies (Additional file 7) were 
incubated with sections for 48 h at 4 °C with gentle agi-
tation. Sections were washed 3 times in 0.1% Tween 20 
1× PBS for 15  min each and then incubated with fluo-
rescently labeled secondary antibodies (Additional file 7) 
for 24 h at 4 °C in the dark with gentle agitation. Sections 
were washed 4 times in 0.1% Tween 20 plus 1× PBS for 
15 min each. Nuclei were labeled by adding TOPRO-3 at 
1:1000 dilution in the third wash. Sections were mounted 
on glass slides with Vectashield (Vector Laboratories, 
Burlingame, CA) mounting reagent. Confocal images 
were obtained using a LSM 510 META NLO multiphoton 
microscope (Zeiss, Oberkochen, Germany). Images were 
taken using 10× and 43× (oil) objectives. Rostral migra-
tory stream images were taken at 10× magnification, and 
then images were then stitched together. For resolution 
of individual cell images in vivo Z-stack images of 8–11 
slices were used.
Analysis of Ube3aYFP in myenteric neurons
Immunofluorescence imaging of  Ube3aYFP
Ube3amYFP/p+ and Ube3am+/pYFP adult mice (6-week-old; 
n =  3/genotype) were processed and immunostained as 
described above. Confocal images of Auerbach’s ganglia 
(8–10 per animal) were obtained using a 43× (oil) objec-
tive. Images were imported into ImageJ and converted to 
the RGB color format. The Plot Profile feature was then 
used to determine the median gray value of  Ube3aYFP in 
individual neurons (RBFOX3 positive) as described above.
Statistical analysis
A mixed-effect model was used to examine the effect of 
allele (maternal and paternal) on  Ube3aYFP protein lev-
els, with sample ID as a random effect to account for 
repeated measurements of neurons within an individual 
animal.
Statistics
Inferential analyses were performed using JMP  Pro® (ver-
sion 12). Mixed-effect models were used for analyses 
involving repeated measures of cells/tissues from an indi-
vidual animal. The degrees of freedom were calculated 
using the Kenward–Roger correction.
Charts
Charts were generated using JMP  Pro® (version 12) and 
formatted in Adobe Illustrator.
Additional files
Additional file 1: Table S1. Pair-wise comparisons of maternal and 
paternal Ube3a transcript levels.
Additional file 2: Table S2. Pair-wise comparisons of UBE3A transcript 
levels.
Additional file 3: Table S3. Pair-wise comparisons of UBE3A transcript 
levels.
Additional file 4: Table S4. RNA-seq analysis of UBE3A allelic expression 
in opossum brain.
Additional file 5: Figure S1. Alignment of mouse, opossum, and human 
Ube3a/UBE3A amino acid sequences. (A) ClustalW alignment of amino 
acid sequences of human UBE3A isoform 3, mouse Ube3a isoform 2, and 
opossum UBE3A. (B) Percent identity values of pair-wise comparisons of 
UBE3A/Ube3a among human, mouse, and opossum. Values represent 
conservative, semiconservative, non-conserved, and insertion/deletion 
percent identity.
Additional file 6: Figure S2. (A-C) Immunofluorescence images of 
paternal  Ube3aYFP protein expression in the lateral ventricle of adult 
Ube3a+/YFP mice. (D) Immunofluorescence image of maternal  Ube3aYFP 
protein expression in the lateral ventricle of adult Ube3aYFP/+ mice. (E) 
Immunofluorescence images of maternal  Ube3aYFP protein expression 
in the lateral ventricle, subventricular zone, rostral migratory stream, 
olfactory bulb, and adjacent cortical neurons in Ube3aYFP/+ mice. (F) 
Immunofluorescence images of maternal  Ube3aYFP protein expression in 
the granular cell layer and subgranular zone of Ube3aYFP/+ mice.
Additional file 7: Table S5. List of antibodies used for western blot and 
immunofluorescence analyses.
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